An association between ABO group and HLA antibody detection

Transfusion

Volumn 57, Issue 2, 2017, Pages 313-318

  Dunbar, Nancy M ^a   Yazer, Mark H ^b   Bravo, Marjorie D ^c   Kamel, Hany T ^c   Gorlin, Jed ^d   Norris, Philip J ^e   Williamson, Phillip C ^f   Vassallo, Ralph R ^c,g  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^c Blood Systems Incorporated   (United States)

^d Memorial Blood Centers of Minnesota   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f CREATIVE TESTING SOLUTIONS   (United States)

^g Biomedical Excellence for Safer Transfusion (BEST) Collaborative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; ALLOANTIBODY; BLOOD GROUP ABO SYSTEM; HLA ANTIGEN;

ANTIBODY DETECTION; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; PARITY; PREGNANCY; SCREENING TEST; THROMBOCYTOPHERESIS; ADULT; BLOOD; CLINICAL TRIAL; MULTICENTER STUDY;

ABO BLOOD-GROUP SYSTEM; ADULT; FEMALE; GRAVIDITY; HLA ANTIGENS; HUMANS; ISOANTIBODIES; PLATELETPHERESIS; PREGNANCY;

EID: 84997120311     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13901     Document Type: Article

References (13)

1. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2014 [Internet]. 2014 [cited 2016 May 10]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM459461.pdf.
2. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757–67.
3. Middelburg RA, van Stein D, Briët E, et al. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008;48:2167–76.
4. Triulzi DJ, Kleinman S, Kakaiya RM, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009;49:1825–35.
5. Reil A, Keller-Stanislawski B, Günay S, et al. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008;95:313–7.
6. Cresswell P. Regulation of HLA class I and class II antigen expression. Br Med Bull 1987;43:66–80.
7. Standards for blood banks and transfusion services. 30th ed. Bethesda (MD): AABB Press; 2016.
8. Vassallo RR, Hsu S, Einarson M, et al. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy. Transfusion 2010;50:1766–77.
9. Lopes LB, Fabron A Jr, Chiba AK, et al. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors. Transfusion 2010;50:902–8.
10. Carrick DM, Johnson B, Kleinman SH, et al. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff. Transfusion 2011;51:1105–16.
11. Martin I, Szczepiorkowski ZM, Dunbar NM. Are group O donors more likely to make anti-HLA antibodies than non-group O donors [abstract]? Transfusion 2015;55(Suppl3):97A.
12. Mengoli C, Bonfanti C, Rossi C, et al. ABO blood group and fertility: a single-centre study. Blood Transfus 2015;13:521.
13. Carr R, Hutton JL, Jenkins JA, et al. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 1990;75:408–13.